Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Encouraging findings from phase IIb study of tarafenacin in overactive bladder

April 11, 2013

Mitsubishi Pharma launches BindRin in Germany and Austria

April 4, 2013

Benefits demonstrated for onabotulinumtoxinA in patients with OAB

March 27, 2013

Improved tolerability of tolterodine/pilocarpine fixed-dose combination without loss of efficacy

March 19, 2013

Vifor Pharma reports new regulatory submission for PA-21 in Switzerland

March 13, 2013

Health Canada approves mirabegron

March 11, 2013

DSP and Nippon Shinyaku sign Japanese agreement for SMP-986

March 8, 2013

OPKO Health completes acquisition

March 6, 2013

FDA agrees with La Jolla Pharmaceutical's proposed IND for LJPC-501

March 5, 2013

Ventana and Biocare Medical sign license agreement for diagnosis of prostate lesions

March 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...